Full article available to subscribers
ClinicalA 49-year-old male with end stage renal disease (ESRD) on haemodialysis was referred for further management of painful, extensive bilateral lower extremity ulcerations present for 8 months (Figure 1). Figure 1. Lower extremity ulceration and overlying eschar Significant labs were leukocytosis, elevated calcium-phosphorus product (CaxP) of 97.5 mg2/dl2 and parathyroid hormone (PTH) level of 3708 pg/ml (10-60). Biopsy of the cutaneous lesions revealed epidermal and dermal necrosis, thrombosis and calcifications in small blood vessels of subcutis (Figure 2). Figure 2. (A) Skin biopsy showing dermal necrosis with neutrophilic infiltration, subcutaneous arterial vessel with thrombosis, marked intimal proliferation and near circumferential calcification causing occlusion of the lumen. H&E magnification 00d7100; (B) Inset showing the thrombosed vessel with circumferential calcification in the vessel wall (black arrows). H&E magnification 00d7400 What is the diagnosis? Answer and Discussion
Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney International 2001;60(1):324-332.Riegert-Johnson DL, Kaur JS, Pfeifer EA. Calciphylaxis associated with cholangiocarcinoma treated with low molecular-weight heparin and vitamin K. Mayo Clin Proc 2001;76:749-52.Ozbalkan Z, Calguneri M, Onat AM, Ozturk MA. Development of calciphylaxis after long-term steroid and methotrexate use in a patient with rheumatoid arthritis. Ann Intern Med 2005;44:1178-81.Vincent M. Brandenburg MC, Ketteler M. Calciphylaxis: a still unmet challenge.. Journal of Nephrology 2011;24(2):142-148.Bishop J, Brown E, Podesta A, et al. Surgical management of calciphylaxis associated with primary hyperparathyroidism: A case report and review of the literature. International Journal of Endocrinology 2010, Article ID 823210, doi:10.1155/2010/823210. http://www.hindawi.com/journals/ije/2010/823210/
Sign in to view your account and access
the latest publications by the NZMJ.
Don't have an account?
Let's get started with creating an account.
Already have an account?
Become a member to enjoy unlimited digital access and support the ongoing publication of the New Zealand Medical Journal.
The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers. Institutions are encouraged to subscribe. The value of institutional subscriptions is essential to the NZMJ, as supporting a reputable medical journal demonstrates an institution’s commitment to academic excellence and professional development. By continuing to pay for a subscription, institutions signal their support for valuable medical research and contribute to the journal's continued success.
Please email us at nzmj@pmagroup.co.nz